8,000 Shares in Teleflex Incorporated $TFX Acquired by Tejara Capital Ltd

Tejara Capital Ltd purchased a new position in Teleflex Incorporated (NYSE:TFX) during the third quarter, Holdings Channel reports. The fund purchased 8,000 shares of the medical technology company’s stock, valued at approximately $979,000.

Other institutional investors also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Teleflex by 57.9% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after buying an additional 77 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new stake in Teleflex in the third quarter worth $35,000. Quent Capital LLC purchased a new stake in shares of Teleflex in the third quarter worth $38,000. True Wealth Design LLC increased its holdings in shares of Teleflex by 10,333.3% during the second quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock valued at $37,000 after acquiring an additional 310 shares in the last quarter. Finally, Cullen Frost Bankers Inc. increased its holdings in shares of Teleflex by 496.7% during the third quarter. Cullen Frost Bankers Inc. now owns 358 shares of the medical technology company’s stock valued at $44,000 after acquiring an additional 298 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Performance

TFX stock opened at $104.40 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.57 and a quick ratio of 1.53. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $184.34. The company has a market cap of $4.61 billion, a P/E ratio of -14.20, a price-to-earnings-growth ratio of 1.38 and a beta of 0.93. The stock’s fifty day moving average price is $116.10 and its 200-day moving average price is $119.60.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, beating analysts’ consensus estimates of $3.38 by $0.29. The company had revenue of $892.90 million for the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.Teleflex’s revenue was up 19.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. On average, equities analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, November 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.3%. Teleflex’s dividend payout ratio (DPR) is presently -18.50%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on TFX shares. Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Royal Bank Of Canada reissued a “sector perform” rating and set a $135.00 price target on shares of Teleflex in a research report on Wednesday, December 17th. Needham & Company LLC upgraded Teleflex from a “hold” rating to a “buy” rating and set a $138.00 target price on the stock in a research note on Tuesday. Finally, Truist Financial boosted their price target on Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research note on Thursday, December 18th. Two analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $139.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.